Skip to content

Released Mar 29, 2016, during market hours

10-K filed Mar 29, 2016, 89 days after period end · 0001493152-16-008343

Q4 2015 · 10-K
Revenue$8.16M−9.0% vs Q4 2014+85.9% vs Q3 2015
Net Income-$1.26MN/M vs Q4 2014N/M vs Q3 2015
EPS Diluted-$0.07N/M vs Q4 2014N/M vs Q3 2015
Gross Profit$4,788,000−18.8%
Operating Incomederived-$1,242,000N/M
Operating Cash Flowderived-$1,012,000N/M
Free Cash Flowderived-$1,052,000N/M
Margins · derived
Gross margin58.7%−7.1 pt vs Q4 2014
Operating margin-15.2%−7.7 pt vs Q4 2014
Net margin-15.4%−7.9 pt vs Q4 2014

What the release said

No earnings release is on file for this quarter. Its figures came with the 10-K.

Same quarter

MetricQ4 2015Q4 2014Q4 2013Q4 2012
Revenue$8.16M$8.97M$9.60M$9.08M
Net Income-$1.26M-$676.00K$597.00K$453.00K
EPS Diluted-$0.07-$0.05$0.04$0.04

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

ProPhase Labs, Inc. · CIK 868278 · Engraved from SEC EDGAR